222 related articles for article (PubMed ID: 6349256)
21. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
Ehmann TS; Delva NJ; Beninger RJ
J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
[TBL] [Abstract][Full Text] [Related]
22. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
23. High dose flupenthixol decanoate in chronic schizophrenia.
McCreadie RG; Flanagan WL; McKnight J; Jorgensen A
Br J Psychiatry; 1979 Aug; 135():175-9. PubMed ID: 387151
[TBL] [Abstract][Full Text] [Related]
24. Clinical trial of flupenthixol decanoate in chronic withdrawn schizophrenic patients.
Vichaiya V
J Med Assoc Thai; 1980 Apr; 63(4):205-9. PubMed ID: 6991627
[No Abstract] [Full Text] [Related]
25. Peroral and parenteral administration of long-acting neuroleptics: a double-blind study of penfluridol compared to flupenthixol decanoate in the treatment of schizophrenia.
Gerlach J; Kramp P; Kristjansen P; Lauritsen B; Lühdorf K; Munkvad I
Acta Psychiatr Scand; 1975 Aug; 52(2):132-44. PubMed ID: 1096541
[TBL] [Abstract][Full Text] [Related]
26. [Comparative study of the effects of fluphenazine-depot and flupenthixol-depot in the treatment of schizophrenic psychoses].
Bilikiewicz A; Sep-Kowalikowa B
Psychiatr Pol; 1976; 10(4):359-66. PubMed ID: 981411
[No Abstract] [Full Text] [Related]
27. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
Turbott J; Villiger J; Hunter L
Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
[TBL] [Abstract][Full Text] [Related]
28. Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
Haider I
J Pak Med Assoc; 1985 Sep; 35(9):286-9. PubMed ID: 3934417
[No Abstract] [Full Text] [Related]
29. A comparative trial of depot pipothiazine.
Steinert J; Neder A; Erba E; Pugh CR; Robinson C; Priest RG
J Int Med Res; 1986; 14(2):72-7. PubMed ID: 2870944
[TBL] [Abstract][Full Text] [Related]
30. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
Chouinard G; Annable L; Ross-Chouinard A
Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
[No Abstract] [Full Text] [Related]
31. Depression-inducing and antidepressive effects of neuroleptics. Experiences with flupenthixol and flupenthixol decanoate.
Pöldinger W; Sieberns S
Neuropsychobiology; 1983; 10(2-3):131-6. PubMed ID: 6674820
[TBL] [Abstract][Full Text] [Related]
32. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
McKane JP; Robinson AD; Wiles DH; McCreadie RG; Stirling GS
Br J Psychiatry; 1987 Sep; 151():333-6. PubMed ID: 3322467
[TBL] [Abstract][Full Text] [Related]
33. Flupenthixol versus combined fluphenazine-nortriptyline in depressive illness.
Conway JF
Practitioner; 1981 Mar; 225(1353):400-4. PubMed ID: 7022433
[No Abstract] [Full Text] [Related]
34. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Cookson JC; Kennedy NM; Gribbon D
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
[TBL] [Abstract][Full Text] [Related]
35. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
McLaren S; Cookson JC; Silverstone T
Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
[TBL] [Abstract][Full Text] [Related]
36. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
37. Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.
Ahlfors UG; Baastrup PC; Dencker SJ; Elgen K; Lingjaerde O; Pedersen V; Schou M; Aaskoven O
Acta Psychiatr Scand; 1981 Sep; 64(3):226-37. PubMed ID: 7324992
[TBL] [Abstract][Full Text] [Related]
38. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders.
Quraishi S; David A
Cochrane Database Syst Rev; 2000; (2):CD001470. PubMed ID: 10796442
[TBL] [Abstract][Full Text] [Related]
39. [Experience with depot neuroleptics].
Arató M; Erdós A
Orv Hetil; 1979 Apr; 120(17):1015-21. PubMed ID: 372888
[No Abstract] [Full Text] [Related]
40. The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Johnson DA; Pasterski G; Ludlow JM; Street K; Taylor RD
Acta Psychiatr Scand; 1983 May; 67(5):339-52. PubMed ID: 6135298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
